Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification

被引：0
|
作者：
Agersborg, Sally [1 ]
Mixon, Christopher [1 ]
Thanh Nguyen [1 ]
Aithal, Sramila [2 ]
Blocker, Forrest [1 ]
Weiss, Lawrence [1 ]
Gasparini, Robert [1 ]
Jiang, Shiping [1 ]
Chen, Wayne [1 ]
Hess, Gregory [3 ]
Albitar, Maher [1 ]
机构：
[1] NeoGenomics Inc, Aliso Viejo, CA USA
[2] Canc Treatment Ctr Amer, Philadelphia, PA USA
[3] Symphony Hlth, Conshohocken, PA USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-4524
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4524
引用
收藏
页数：2
相关论文
共 50 条
  • [41] HER-2 gene amplification by fluorescence in situ hybridization (FISH) compared with immunohistochemistry (IHC) in breast cancer: a study of 528 equivocal cases
    Han Zhang
    Guoping Ren
    Xiaoling Wang
    Jing Zhao
    Hongtian Yao
    Yanfeng Bai
    Wang Bo
    Breast Cancer Research and Treatment, 2012, 134 : 743 - 749
  • [42] Quantification of HER2 autoantibodies in the amplification phenomenon of HER2 in breast cancer
    Lauterlein, Jens-Jacob L.
    Petersen, Eva R. B.
    Olsen, Dorte Aa
    Ostergaard, Birthe
    Brandslund, Ivan
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (05) : 877 - 883
  • [43] Comparison of fluorescence in situ hybridization (FISH) with immunohistochemistry (IHC) for detection of HER2/neu amplification/overexpression in breast cancer.
    Sun, G
    Morales, JS
    Wilz, S
    McKee, C
    Amberson, J
    Gersen, S
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 107 - 107
  • [44] HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry
    Morsberger, Laura
    Pallavajjala, Aparna
    Long, Patty
    Hardy, Melanie
    Park, Rebecca
    Parish, Rebecca
    Nozari, Azin
    Zou, Ying S.
    CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [45] Impact of the 2013 ASCO/CAP Guideline Recommendations for HER2Testing of Invasive Breast Carcinoma: A Focus on Tumors Assessed as Equivocal for HER2 Gene Amplification By FISH
    Bethune, Gillian
    van Zanten, Daniel Veldheijzen
    Younis, Tallal
    Rayson, Daniel
    Thompson, Kara
    Barnes, Penny
    LABORATORY INVESTIGATION, 2015, 95 : 35A - 35A
  • [46] Impact of the 2018 ASCO/CAP HER2 guidelines update for HER2 testing by FISH in breast cancer
    Xu, Bin
    Shen, Jianguo
    Guo, Wenhao
    Zhao, Wenhe
    Zhuang, Yiyu
    Wang, Linbo
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (02) : 251 - 255
  • [47] HER2 Gene Amplification in ER-positive HER2 Immunohistochemistry 0 or 1+Breast Cancer With Early Recurrence
    Yamashita, Hiroko
    Ishida, Naoko
    Hatanaka, Yutaka
    Hagio, Kanako
    Oshino, Tomohiro
    Takeshita, Takashi
    Kanno-Okada, Hiromi
    Shimizu, Ai
    Hatanaka, Kanako C.
    Matsuno, Yoshihiro
    ANTICANCER RESEARCH, 2020, 40 (02) : 645 - 652
  • [48] Equivocal (2+) HER-2/neu results by immunohistochemistry in breast carcinoma: "normalizing" reduces need for FISH testing
    Santiano, Estrella J.
    Salvatore, P. S.
    Hoda, A. S.
    VIRCHOWS ARCHIV, 2009, 455 : 192 - 192
  • [49] The Effect of HER2 Amplification in HER2+Breast Cancer
    Lee, M. K.
    Hurvitz, S. A.
    Tran, B. N.
    Fu, Y.
    Chung, D. U.
    Gornbein, J.
    Apple, S. K.
    Chang, H. R.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S45 - S45
  • [50] Practice Patterns of HER2 in situ Hybridization Testing in the Setting of Equivocal Immunohistochemistry in the United States
    Iorgulescu, B.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2022, 24 (10) : S116 - S116
12345